BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

CAPS Rating: 1 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Recs

0
Player Avatar pchop123 (79.57) Submitted: 11/21/2012 3:42:14 PM : Underperform Start Price: $1.63 BCRX Score: +4.99

likely to drop precipitously near term

Featured Broker Partners


Advertisement